Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0653C (ezetimibe/atorvastatin) vs higher-dose atorvastatin in hypercholesterolemia
CTR20190172Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin + ezetimibe in hypercholesterolemia, sponsored by Merck & Co.. Started Mar 2019; status: completed.
02
Drugs
atorvastatin + ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on CTR20190172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190172.